Three-dimensional Contrast-Enhanced Ultrasonic Cholangiography: a New Technique for Delineation of the Biliary Tract in a Liver Donor.
Er-Jiao Xu,Ren Mao,Rong-Qin Zheng,Min-Qiang Lu,Mei Liao,Jie Ren,Kai Li
DOI: https://doi.org/10.1002/lt.21783
2009-01-01
Liver Transplantation
Abstract:Currently, intraoperative cholangiography using a radio-opaque contrast medium is widely used for visualizing the biliary tract before donor hepatectomy in living donor liver transplantation (LDLT). However, radiation exposure and adverse reactions to intravenous iodinated contrast have limited its clinical application. Ultrasonography could overcome these limitations if the bile ducts could be visualized adequately. Contrast-enhanced ultrasound (CEUS) and 3-dimensional (3D) CEUS have been successfully used for depicting blood flow by the intravenous injection of microbubble contrast media.1, 2 Recently, the value of intracavitary administration of microbubble contrast media in the diagnosis of vesico-ureteric reflux has been reported.3 We describe the use of 3D contrast-enhanced ultrasonic cholangiography (CEUSC) to delineate the biliary tree in an adult living liver donor through the injection of microbubble contrast media into the bile ducts intraoperatively. 2D, 2-dimensional; 3D, 3-dimensional; CEUS, contrast-enhanced ultrasound; CEUSC, contrast-enhanced ultrasonic cholangiography; CHD, common hepatic duct; LDLT, living donor liver transplantation; LHD, left hepatic duct; RAD, right anterior duct; RHD, right hepatic duct; RPD, right posterior duct. A 37-year-old woman with hepatocellular carcinoma associated with hepatitis B virus–related cirrhosis and within the Milan criteria was admitted to the hospital for LDLT. Both the recipient and the donor, the recipient's 25-year-old nephew, were enrolled in our study. No LDLT contraindication was found in the donor or recipient after the preoperative evaluation. Written informed consent was obtained from the donor and recipient. The study was approved by the institutional ethics review board and was in compliance with the Declaration of Helsinki. After the donor's open cholecystectomy, cannulation of the cystic duct was performed. The biliary system was examined with an ultrasound scanner (IU22, Philips Medical System, Bothell, WA) equipped with a low–mechanical index, real-time, gray-scale, pulse-inversion harmonics imaging mode. A V6-2 volume convex-array transducer (frequency range: 2-6 MHz) was clothed in a sterile sleeve and placed on the diaphragmatic surface of the liver directly. 3D color Doppler flow imaging was used to simulate the appropriate volume angle so that the biliary anatomy could be included in the volume data without signal loss. The volume angle was set at 55 degrees. SonoVue (BR1, Bracco SpA, Milan, Italy), the second general ultrasonic contrast medium consisting of phospholipid-stabilized microbubbles of sulfur hexafluoride (SF6), was used for CEUS imaging. After the preparation of a vial of SonoVue through the mixing of the contents with 5 mL of a 0.9% saline solution, a dose of 1 mL of the contrast medium was withdrawn into a syringe and diluted with 20 mL of a 0.9% saline solution. A total volume of 21 mL of the diluted contrast medium was injected through the cystic duct cannula bolus after temporary clamping of the distal common bile duct. The 3D volume data were acquired on the scanner with the following parameters to provide sufficient tissue cancellation and visualization of the microbubbles: the focus was set at the bottom of the image, the general 2-dimensional (2D) option was used, the mechanical index was 0.10, the gain was 65%, and the compression was 36. When the ultrasonic contrast medium was injected into and filled the intrahepatic bile ducts, the transducer was fixed, and the 3D volume scanning was performed automatically. Following 3D CEUSC, the distal common bile duct was unclamped to allow drainage of the contrast medium. The data were reconstructed and processed with QLab 6.0 software (Philips Medical System), which was equipped in the IU22 ultrasound scanner. After the 3D reconstruction mode was entered, the 3D image was rotated to obtain the optimal viewing direction of the biliary tree. The image threshold was raised properly to suppress the artifacts. Some other unwanted echoes could be eliminated manually. The brightness, smoothness, transparency, and so on were adjusted to produce higher quality 3D images. The images were displayed dynamically from various angles to demonstrate the spatial relationships between different branches of the bile ducts. Intraoperative cholangiography was performed with fluoroscopic guidance (Biplanar 500, Swemac Medical Appliances AB, Sweden). Several images were obtained after the injection of 10 mL of dilute meglumine diatrizoate (Hansen Pharmaceutical Co., Ltd., Yiyang, Hunan, China) into the cystic duct. On 3D CEUSC, the biliary tree was clearly visualized from the common hepatic duct down to the fourth-order intrahepatic bile ducts. No anatomical variation of the biliary tract was found (Fig. 1). This was confirmed by intraoperative cholangiography and surgery. The entire 3D CEUSC procedure was completed within 15 minutes. No adverse reactions to the microbubble contrast medium occurred in the donor or recipient during the operation or in the 6-month follow-up. (A) Three-dimensional contrast-enhanced ultrasonic cholangiography demonstrates the common, right, and left hepatic ducts (CHD, RHD, and LHD, respectively), right anterior and posterior ducts (RAD and RPD, respectively), fourth-order branches of the right bile duct (arrow), and segmental ducts (S1-S8). (B) After the rotation of panel A on the x axis, different biliary branches can be clearly distinguished from one another on 3-dimensional contrast-enhanced ultrasonic cholangiography. (C) Intraoperative cholangiography confirms this normal biliary anatomy. LDLT has been accepted as the most effective alternative to overcome the shortage of available cadaveric liver grafts. However, the surgical techniques for LDLT are much more challenging than those for cadaveric liver transplantation.4, 5 The success of LDLT requires a full understanding of liver anatomy, including the vascular and biliary systems. Anatomical variations of the biliary tract occur in more than 42% of the population.6 A definite and precise evaluation of biliary anatomy is essential for the safety of donors and recipients. Conventional ultrasound has been used to evaluate the vascular system during LDLT.7 However, it is limited in displaying the nondilated biliary tree because the echo difference between the bile ducts and the surrounding liver tissue is insufficient. Microbubble contrast media could obviously enhance the echogenicity of the vessels and bile ducts. Robert et al.8 used 2D CEUS to display the porcine biliary tree by injecting microbubbles into the bile ducts. In our study, with the help of 3D CEUSC, the whole biliary tree could be visualized from any direction, and this could facilitate the surgeon's understanding of the biliary anatomy and reduce the risk of bile duct injury during graft harvesting in LDLT. The image quality was lower in the left lobe of the liver, especially in the left lateral lobe. This may be ascribed to an insufficient volume scanning zone to cover the entire length of the longer left hepatic duct and its branches. Methods of improving the visualization of the biliary tree in the left liver will need to be explored with more cases. However, the normal anatomy of the biliary tree was clearly demonstrated in our case. In conclusion, we have described the successful use of intraoperative 3D CEUSC to delineate the anatomy of the biliary tract. It may be an alternative to intraoperative cholangiography in the evaluation of biliary anatomy before graft harvesting in living liver donors. The authors thank Dr. Margaret Pui for her editorial assistance in the preparation of this article.